scholarly article | Q13442814 |
P356 | DOI | 10.2174/13816128130303 |
P698 | PubMed publication ID | 23394093 |
P50 | author | Gianluca Svegliati-Baroni | Q72323940 |
P2093 | author name string | Samuele De Minicis | |
Chris Day | |||
P433 | issue | 29 | |
P921 | main subject | pathogenesis | Q372016 |
hepatocellular carcinoma | Q1148337 | ||
P304 | page(s) | 5239-5249 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | Current Pharmaceutical Design | Q5195068 |
P1476 | title | From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights | |
P478 | volume | 19 |
Q34070770 | A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease |
Q60302074 | Bioinformatics analysis of key differentially expressed genes in non-alcoholic fatty liver disease mice models |
Q33568261 | Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis |
Q40922247 | Comments on "NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis". |
Q56343202 | Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis |
Q34309876 | Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs). |
Q92990488 | Gut microbiota, fatty liver disease, and hepatocellular carcinoma |
Q35172679 | HCC development is associated to peripheral insulin resistance in a mouse model of NASH. |
Q26764911 | Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play |
Q47138651 | Hepcidin in morbidly obese women with non-alcoholic fatty liver disease |
Q45061974 | Human germline hedgehog pathway mutations predispose to fatty liver. |
Q46443002 | Intermittent calorie restriction largely counteracts the adverse health effects of a moderate-fat diet in aging C57BL/6J mice |
Q36561514 | LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease |
Q26852606 | MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease |
Q41969545 | Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis |
Q30277911 | NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice |
Q47958825 | Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice. |
Q91992943 | PPAR δ inhibition protects against palmitic acid-LPS induced lipidosis and injury in cultured hepatocyte L02 cell |
Q41457655 | Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. |
Q37377220 | miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease. |
Search more.